Scientists have translated nanoscale experimental and computational data into precise 3D representations of bacteria, yeast ...

Life expectancy in New York City has been falling. A new plan to address it includes basic income, prescribing parks, and ...

Aging research has experienced substantial advancements in the past decade, particularly in understanding the interrelation ...

Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to redirect one of its cancer programs toward ...

Discover how explainable AI (xAI) and real-world data (RWD) improve clinical decision-making in oncology by identifying key prognostic markers across multiple cancer types.

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images.

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

Fewer people than before are being diagnosed with and dying from cancer in Appalachia, but cancer incidence and death rates ...

Nuvectis is also advancing NXP900 for YES1/SRC-expressing solid tumors, with promising early data showing no dose-limiting ...

One of the most agonizing experiences a cancer patient suffers is waiting without knowing: waiting for a diagnosis, waiting ...

Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the ...

A new state dashboard lets policymakers across Kansas see mortality rates, risk factors and other detailed data about cancer in their communities, and it has good news and bad news about the disease ...